These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 7453783

  • 1. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW.
    N Engl J Med; 1981 Feb 26; 304(9):497-503. PubMed ID: 7453783
    [Abstract] [Full Text] [Related]

  • 2. Complement activation and neutropenia occurring during cardiopulmonary bypass.
    Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock PR, Jacob HS.
    J Thorac Cardiovasc Surg; 1981 Mar 26; 81(3):370-7. PubMed ID: 6970304
    [Abstract] [Full Text] [Related]

  • 3. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A, Religa Z, Kokot F, Knapik P, Wnuk R, Komarski K, Wojnar J, Pietrzycki A, Skiba J.
    Kardiol Pol; 1992 Mar 26; 36(2):67-72. PubMed ID: 1583828
    [Abstract] [Full Text] [Related]

  • 4. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC, Pluth JR, Schaff HV, Orszulak TA, Homburger HA, Solis E, Kaye MP, Clancy MS, Kolff J, Deeb GM.
    J Thorac Cardiovasc Surg; 1986 Feb 26; 91(2):252-8. PubMed ID: 3511328
    [Abstract] [Full Text] [Related]

  • 5. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug 26; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 6. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M, Bengtson A, Karlsson K, Heideman M.
    Obstet Gynecol; 1989 Apr 26; 73(4):551-6. PubMed ID: 2784554
    [Abstract] [Full Text] [Related]

  • 7. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
    Soejima K, Koyanagi H, Endo M, Hashimoto A, Imai Y.
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb 26; 35(2):200-4. PubMed ID: 3495614
    [No Abstract] [Full Text] [Related]

  • 8. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Feb 26; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 9. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ, Sumner H.
    Invest Ophthalmol Vis Sci; 1986 Aug 26; 27(8):1288-92. PubMed ID: 3488296
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
    Kreutzer DL, McCormick JR, Despins A, Moore M, Rousou JH, Dobbs W, Engleman RN.
    J Exp Pathol; 1984 Aug 26; 1(3):183-7. PubMed ID: 6336305
    [Abstract] [Full Text] [Related]

  • 11. Anaphylatoxin generation in multisystem organ failure.
    Heideman M, Hugli TE.
    J Trauma; 1984 Dec 26; 24(12):1038-43. PubMed ID: 6334754
    [Abstract] [Full Text] [Related]

  • 12. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC, Duchateau J, Grabitz RG, Faymonville ML, Messmer BJ, Buro-Rathsmann K, von Bernuth G.
    J Thorac Cardiovasc Surg; 1993 Dec 26; 106(6):978-87. PubMed ID: 8246580
    [Abstract] [Full Text] [Related]

  • 13. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S.
    Arthritis Rheum; 1986 Sep 26; 29(9):1085-9. PubMed ID: 3489467
    [Abstract] [Full Text] [Related]

  • 14. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
    Wolach B, Coates TD, Hugli TE, Baehner RL, Boxer LA.
    J Lab Clin Med; 1984 Feb 26; 103(2):284-93. PubMed ID: 6607301
    [Abstract] [Full Text] [Related]

  • 15. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
    Yamasaki M.
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb 26; 37(2):234-41. PubMed ID: 2788676
    [Abstract] [Full Text] [Related]

  • 16. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
    Tamiya T, Maeo Y, Okada T, Ogoshi S, Fujimoto S, Yasui H.
    J Thorac Cardiovasc Surg; 1992 Jan 26; 103(1):78-86. PubMed ID: 1728718
    [Abstract] [Full Text] [Related]

  • 17. Anaphylatoxin formation in extracorporeal circuits.
    Chenoweth DE.
    Complement; 1986 Jan 26; 3(3):152-65. PubMed ID: 3492330
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
    Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR.
    N Engl J Med; 1985 Feb 21; 312(8):457-62. PubMed ID: 3881672
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of complement activation by high-dose corticosteroids in total hip arthroplasty.
    Gammer W, Bengtson A, Heideman M.
    Clin Orthop Relat Res; 1988 Nov 21; (236):205-9. PubMed ID: 3263243
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 21; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.